Is RGA a Buy or a Sell? The Bull and Bear Case (2026)

The most optimistic published target on RGA is $302.00, +24.2% from the $243.13 price as of August 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

The most pessimistic published target is $223.00, -8.3% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Reinsurance Group of America is worth if the risks below bite instead of the drivers above.

The clearest risk is the one the business exists to take. Mortality and morbidity experience can move against a book of treaties written years earlier, as it did in 2020 and 2021 when pandemic claims pushed RGA to losses, and the same sensitivity now runs in both directions because longevity exposure in pension risk transfer and annuity blocks pays off when people die earlier than assumed. A single large block priced on wrong assumptions is difficult to unwind. Credit risk has grown alongside the asset-intensive strategy: a ~$145 billion portfolio backing long-dated liabilities carries corporate credit, commercial mortgage and private-asset exposure, and a downgrade cycle would hit capital before it hit income. Accounting adds noise that is easy to mistake for economics. Embedded derivatives on funds-withheld treaties and other adjustments put a $1.88 per share gap between second quarter net income of $7.01 and adjusted operating income of $8.89, and book value per share swings with AOCI, which stood at $209.73 including AOCI versus $173.77 excluding it at June 30, 2026. Management flagged ~$0.83 per share of one-time items in the quarter that it says are not indicative of trend, so extrapolating the record print overstates the base. Competition for asset-intensive blocks comes from private-equity-backed platforms with cheaper capital, which compresses returns on exactly the deals driving growth. Regulatory and tax changes matter more than for most financials: potential Hong Kong tax law changes were called out for Asia Pacific, and Bermuda and U.S. capital rules shape how blocks are structured. Ratings are load-bearing, since cedents choose reinsurers partly on financial strength. With ~$5.7 billion of debt and only ~65 million shares outstanding, both leverage and per-share results amplify whatever happens underneath.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding RGA already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

9 analysts cover RGA, with an average target of $269.33 (+10.8% against $243.13) and a split of 6 buy, 3 hold, 1 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the RGA forecast and price target page.

• Revenue (TTM): ~$25.97 billion for the twelve months to June 30, 2026, up ~19% year over year, versus $23.70 billion in fiscal 2025, $22.11 billion in 2024 and $18.57 billion in 2023. The line combines net premiums with net investment income and fee income, so growth reflects both new reinsurance treaties and the yield earned on assets backing reserves, not unit sales. Reported in U.S. dollars, with material Canadian dollar, sterling, euro and yen exposure translated in.
• Earnings (TTM): ~$1.51 billion of net income and $22.72 of diluted EPS for the twelve months to June 30, 2026, against $1.18 billion and $17.69 in fiscal 2025 and $717 million and $10.73 in 2024. Second quarter 2026 net income was $462 million, or $7.01 per diluted share, versus $180 million and $2.70 a year earlier. Adjusted operating income, the measure management guides to, was $586 million or $8.89 per diluted share in the quarter and $1.048 billion or $15.86 per share for the first half.
• Premiums and segment income (Q2 2026): Net premiums of $4.472 billion in the quarter and $9.067 billion year to date, up 11.0% on a reported basis and 9.3% in constant currency excluding pension risk transfer. Pre-tax adjusted operating income by segment: U.S. and Latin America Traditional $165 million and Financial Solutions $154 million, Asia Pacific Traditional $129 million and Financial Solutions $120 million, EMEA Traditional $39 million and Financial Solutions $133 million, Canada Traditional $38 million and Financial Solutions $18 million, with a $35 million loss in Corporate and Other. Total pre-tax adjusted operating income was $761 million.
• Returns and book value: Trailing twelve-month ROE of 11.5%, adjusted operating ROE of 17.4%, and 18.4% excluding notable items, all above the 13% to 15% intermediate-term target. Book value per share was $209.73 at June 30, 2026, $173.77 excluding AOCI and $174.11 excluding AOCI and the B36 funds-withheld embedded derivative effect, the last of which has compounded at 10.1% a year since the start of 2021. Total equity stood at ~$13.78 billion on ~$167 billion of assets.
• Capital, liquidity and distributions: ~$2.2 billion of estimated excess capital, ~$2.7 billion of deployable capital and $7.2 billion of available liquidity at June 30, 2026, against ~$5.7 billion of total debt and ~$5.29 billion of cash and equivalents. Capital deployed into in-force transactions was $158 million in the quarter and close to $500 million year to date. Shareholder returns totaled $111 million in the quarter, split $61 million of dividends and $50 million of buybacks, after a 5.4% increase in the quarterly dividend to $0.98 per share.
• Market pricing: ~$243 per share in late August 2026 for a market capitalization of ~$15.9 billion on ~65.3 million shares, inside a 52-week range of $178.21 to $251.00. The shares change hands at ~10.7x trailing earnings, ~8.6x forward estimates, ~1.16x reported book value and ~1.40x book excluding AOCI. The dividend of $3.92 annualized yields ~1.6%, and beta sits near 0.46. EV/EBITDA is not calculated for life reinsurers, since debt and investment income are operating inputs rather than financing adjustments.

A double-digit P/E and a small premium to book on an 18% adjusted operating ROE is the market applying a discount for how the returns were earned. Investors have seen life reinsurers report strong mortality quarters and then take reserve charges, and the asset-intensive growth of the past three years adds credit exposure that only reveals itself in a downturn. The forward multiple below the trailing one reflects consensus expecting normalization from the 2026 print rather than continued acceleration.

Rather than asking whether RGA is a buy in the abstract, it tends to help to answer four questions:

• Thesis: do you believe the bull case above, and is it still true today?
• Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
• Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
• Overlap: check whether you already hold RGA indirectly through an index or sector ETF before adding more.

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

• Bull case breaks if: Financial Solutions and the Equitable block stalls in the reported numbers rather than in the narrative around them.
• Bear case breaks if: the clearest risk is the one the business exists to take fails to materialise over several reporting periods while the drivers keep compounding.
• Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the RGA stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about RGA against your real portfolio and see your actual exposure before deciding.